Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223821 · ClinicalTrials.gov registry record · NA
Enhancing Conservative Treatment for Urge Incontinence
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT00223821: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00223821 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00223821, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
The primary objective of this project is to evaluate whether enhancing drug therapy with components of behavioral training, including pelvic floor muscle rehabilitation, results in better outcomes than drug therapy alone for urge incontinence in community-dwelling women.
Primary Outcome
Percent change from baseline in weekly frequency of incontinent episodes immediately post-treatment, derived from baseline and week 8 seven-day bladder diaries.
Interventions
- DRUG Oxybutynin chloride, extended-release, individually-titrated
- BEHAVIORAL Behavior Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2003-09 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00223821 record still lists
NCT00223821 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Oxybutynin chloride, extended-release, individually-titrated is the first listed.
NCT00223821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00223821 about?
NCT00223821 is a clinical study titled "Enhancing Conservative Treatment for Urge Incontinence". The primary objective of this project is to evaluate whether enhancing drug therapy with components of behavioral training, including pelvic floor muscle rehabilitation, results in better outcomes than drug therapy alone for urge incontinence in community-dwelling women.
What is the current status of trial NCT00223821?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2003-09. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00223821?
The interventions under investigation include: Oxybutynin chloride, extended-release, individually-titrated (DRUG), Behavior Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00223821?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00223821's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia